About
Sofregen Inc. is a biomedical company focused on developing and commercializing natural biomaterials from purified silk protein. These materials are designed to enhance soft tissue regeneration in both surgical and aesthetic medical procedures. The company originated from research at Tufts University’s Biomedical Engineering Department and aims to lead in regenerative beauty through innovative products for medical practitioners. Sofregen offers FDA-cleared products such as the Silk Voice® Injectable Implant, which combines silk protein and hyaluronic acid for vocal fold medialization, and the SERI® Surgical Scaffold, a silk-based biological scaffold that supports tissue regeneration in various surgical procedures. The company is also advancing a pipeline of additional silk-based products to expand applications in aesthetic procedures and surgeries, providing unique solutions for medical professionals seeking to improve patient outcomes.
Technologies
Keywords
Company Information
- Employees8
- Founded2014
- Annual Revenue$6000000
- Total Funding$23904666
Location
175 Crossing Blvd, Framingham, Massachusetts, United States, 01702-4472